If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
633.00    -7.00 (-1.09%)
Bid:
632.00
Ask:
634.00
Spread: 2.00 (0.316%)
Market Cap: £608.48m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Full Year Trading Update

20 Apr 2021 07:00

RNS Number : 9515V
discoverIE Group plc
20 April 2021
Β 

For Release

7.00am, 20 April 2021

Β 

discoverIE Group plc

Β 

Full Year Trading Update

Β 

Strong finish ahead of expectations and excellent order growth

Β 

discoverIE Group plc (LSE: DSCV, "discoverIE" or the "Group"), a leading international designer, manufacturer and supplier of customised electronics to industry, today issues a trading update for the year ended 31 March 2021, ahead of the announcement of its preliminary results on 3 June 2021.

Β 

Trading momentum in the final two months of the year continued to strengthen and the Board now expects underlying earnings for the full year to be above the upper end of market expectations.

Group orders increased by 17% organically(1) in the last two months with double digit growth in both divisions and builds on the 10% organic growth of the preceding 4 months, resulting in 12% organic growth for the second half. Orders in the second half were 40% ahead of the first half with a book to bill ratio of 1.19:1. Overall, Group orders were 2% lower organically for the full year and ahead of sales.

Β 

Group sales in the second half were 9% ahead of the first half with a return to organic growth of 1% in the last two months of the year. Organically, second half sales were 3% lower. As a result, Group sales for the full year were 3% lower, and organically 6% lower, being 4% lower in D&M and 8% lower in Custom Supply, driven by stronger performance in our target markets which comprise renewable energy, medical, electrification of transportation and industrial & connectivity, and which now account for over 70% of Group sales.

Β 

Phoenix America and Limitor GmbH, which were acquired during the year and have since been clustered with our Variohm business within the D&M division, performed well and in line with expectations. Both are delivering organic growth in orders and sales.

Β 

The Group remains well funded with good liquidity. Cash generation continued to be strong with gearing (2) at the financial year end reducing to 1.2x. With our target gearing range being 1.5x to 2.0x, there is significant headroom for further acquisitions and the pipeline remains healthy.

Β 

The strong order book and momentum provide a solid base for sustained organic sales growth whilst further investing in growth initiatives. With a clear strategy focused on long-term high quality growth markets, a strong funnel of design wins and acquisition targets, the Group is well positioned to make further progress in the year ahead, in line with its key strategic indicators.

Β 

Β 

Β 

For further information, please contact:

Β 

discoverIE Group plc 01483 544 500

Nick Jefferies Group Chief Executive

Simon Gibbins Group Finance Director

Β 

Buchanan 020 7466 5000

Chris Lane, Toto Berger, Charlotte Slater

discoverIE@buchanan.uk.com

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Notes

1. Growth rates refer to the comparable prior year period unless stated. Organic growth for the Group is calculated at CER and is shown excluding the first 12 months of acquisitions post completion (Sens-Tech was acquired in October 2019, Phoenix in October 2020 and Limitor in February 2021). For the year ended 31 March 2021, the average sterling rate of exchange against the Euro weakened by 2% compared with the average rate last year, and by 2% on average against the three Nordic currencies, while strengthening by 3% compared with the US dollar rate for last year.

2. Gearing ratio is defined as net debt divided by underlying EBITDA (annualised for acquisitions). Proforma gearing reported at the end of January 2021 was 1.35x including the acquisition of Limitor.

Β 

3. This trading update is based upon unaudited management accounts and has been prepared solely to provide additional information on trading to the shareholders of discoverIE Group plc. It should not be relied on by any other party for other purposes. Certain statements made in this update are forward looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this update. Forward looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

Β 

Β 

Notes to Editors:

Β 

About discoverIE Group plc

Β 

discoverIE Group plc is an international group of businesses that designs, manufactures and supplies innovative components for electronic applications.

Β 

The Group provides application-specific components to original equipment manufacturers ("OEMs") internationally. By designing components that meet customers' unique requirements, which are then manufactured and supplied throughout the life of their production, a high level of repeating revenue is generated with long term customer relationships.

Β 

With a focus on key markets driven by structural growth and increasing electronic content, namely renewable energy, medical, electrification of transportation and industrial & connectivity, the Group aims to achieve organic growth that is well ahead of GDP and to supplement that with targeted complementary acquisitions. The Group has an ongoing commitment to reducing the impact of its operations on the environment, while its key markets are aligned with a sustainable future.

Β 

The Group employs c.4,200 people and its principal operating units are located in Continental Europe, the UK, China, Sri Lanka, India and North America.

Β 

The Group is listed on the Main Market of the London Stock Exchange and is in the top quartile of the FTSE Small Cap Index, classified within the Electrical Components and Equipment subsector, and has revenues of over Β£450m.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFLFSRSFIALIL
Date   Source Headline
30th Jan 20207:00 amRNSThird Quarter Trading Update
23rd Jan 20208:59 amRNSHolding(s) in Company
16th Jan 202010:57 amRNSHolding(s) in Company
23rd Dec 20199:26 amRNSHolding(s) in Company
9th Dec 20198:42 amRNSHolding(s) in Company
28th Nov 20197:00 amRNSHalf-year Report
19th Nov 20192:58 pmRNSDirector Declaration
23rd Oct 201910:44 amRNSHolding(s) in Company
23rd Oct 20199:01 amRNSHolding(s) in Company
17th Oct 20191:15 pmRNSResults of Placing
17th Oct 20197:00 amRNSAcquisition & Proposed Placing
10th Oct 20197:00 amRNSTrading Update
2nd Sep 20197:00 amRNSDirector Declaration
25th Jul 20191:38 pmRNSResult of AGM
25th Jul 20197:00 amRNSTrading Update
24th Jul 20199:00 amRNSIssue of Equity
10th Jul 201911:40 amRNSHolding(s) in Company
25th Jun 201911:31 amRNSAnnual Report and Accounts
4th Jun 20197:00 amRNSFinal Results
3rd May 20192:48 pmRNSHolding(s) in Company
1st May 20194:21 pmRNSDirector LTIP Award
30th Apr 20199:00 amRNSDirectorate Change
24th Apr 201911:21 amRNSHolding(s) in Company
18th Apr 201911:57 amRNSDirector/PDMR Shareholding
16th Apr 20191:08 pmRNSDirector Declaration
16th Apr 201911:35 amRNSResults of Placing
16th Apr 20197:01 amRNSAcquisitions & Proposed Placing
16th Apr 20197:00 amRNSTrading Update
18th Mar 20192:52 pmRNSHolding(s) in Company
15th Mar 20197:00 amRNSBoard and Committee Changes
8th Feb 20199:22 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSThird Quarter Trading Update
5th Dec 201810:12 amRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSHalf-year Report
17th Oct 20187:00 amRNSAcquisition
11th Oct 20187:00 amRNSTrading Update
10th Sep 20183:17 pmRNSIssue of Equity
22nd Aug 201811:30 amRNSHolding(s) in Company
26th Jul 20182:45 pmRNSResult of General Meeting
26th Jul 20182:40 pmRNSResult of AGM
26th Jul 20187:00 amRNSTrading Update
11th Jul 20182:17 pmRNSHolding(s) in Company
10th Jul 20187:00 amRNSPublication of Circular and Notice of EGM
26th Jun 20184:46 pmRNSAnnual Report and Accounts
19th Jun 20183:03 pmRNSIssue of Equity
11th Jun 201810:56 amRNSHolding(s) in Company
7th Jun 20184:08 pmRNSDirector/PDMR Shareholding
6th Jun 20189:00 amRNSExercise of share options
5th Jun 20187:00 amRNSFinal Results
19th Apr 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.